In the ever-evolving landscape of patient care and satisfaction, success is gauged not solely by the services provided but by the tangible impact on the lives of those served. RareMed Solutions is proud to maintain a reputation for providing the highest-level of patient satisfaction in the industry, and has continued to do so through the third quarter of 2025, as demonstrated by the team’s recent achievement of a 93-point patient satisfaction survey score from MMIT. RareMed has continued to deliver the highest average patient satisfaction score on MMIT (previously Zitter) scores for over three years running, highlighting our remarkable commitment to excellence.
Unveiling the Impressive Scores
For the third quarter of 2025, RareMed Solutions attained a Net Promoter Score (NPS) of 93% in MMIT’s Patient Satisfaction Survey. This achievement reflects the steadfast dedication of the entire team, who tirelessly strive to ensure each patient receives unparalleled care and support. An NPS of 93 is not merely a statistic; it symbolizes the trust and satisfaction patients place in RareMed Solutions, underscoring the effectiveness of their patient-centered approach. Maintaining scores above 90 throughout 2025, including a record-breaking 100-point score in Q1, further showcases RareMed’s unwavering commitment to excellence.
Moreover, the survey results revealed perfect scores of 100% for Medication Turnaround Time in both the HUB and SP categories, as well as for Refill Delivery Turnaround Time. These scores highlight RareMed’s efficiency and reliability in delivering essential medications, ensuring minimal disruption to patients’ treatment plans.
The survey also included overwhelmingly positive direct patient comments, with no detractor feedback. This positive reinforcement not only affirms RareMed’s efforts but also provides insights into our areas of excellence. The absence of negative feedback is truly a rare achievement, speaking volumes about the exceptional service provided by the team.
The Importance of Patient Satisfaction
Patient satisfaction is the cornerstone of RareMed’s reputation. Every day, we work to set the benchmark for the industry, striving for perfection in patient experience. Every interaction with patients represents an opportunity to provide exemplary service, build trust, and foster long-lasting relationships. The high scores from the MMIT survey reflect a commitment to these principles and the relentless pursuit of excellence in patient care.
As RareMed Solutions celebrates these outstanding achievements, the focus remains on continuous improvement. The goal is to maintain and build upon this success by implementing innovative solutions, enhancing communication strategies, and expanding services to meet the ever-evolving needs of patients. Understanding that the work is never done, RareMed is committed to controlled growth, ensuring that as we expand to support more patients, we continue to listen to patients, gather feedback, and make data-driven decisions that prioritize their well-being and satisfaction.
A Heartfelt Thank You
This achievement would not have been possible without the hard work and dedication of the incredible team at RareMed Solutions. Their expertise, compassion, and commitment to patient care are the driving forces behind this success. Gratitude is also extended to our patients for their trust and positive feedback, inspiring RareMed to strive for even greater heights.
The results of the MMIT Patient Satisfaction Survey for Q3-2025 are a testament to the exceptional care and service provided by RareMed Solutions. With a 93-point NPS, perfect scores in key areas, and significant improvements in communication, RareMed is proud of these accomplishments and excited for what the future holds. Together, the team will continue to make a meaningful impact in the lives of patients, one successful outcome at a time.
About RareMed
RareMed Solutions is the nation’s only concierge patient services provider, focused on rare and complex conditions. RareMed partners with biopharma to transform the lives of patients afflicted with devastating complex conditions by accelerating access to biomedical breakthroughs. RareMed offers case management, co-pay, coupon and financial assistance programs, reimbursement support, nursing support, healthcare professional education, patient adherence & education, and non-commercial pharmacy dispensing services to all fifty states, as well as custom-developed associated support technologies, from its headquarters in Pittsburgh, Pennsylvania and bases across the country.
The company has a breadth of experience developing, transitioning, and maintaining therapy-specific solutions that ensure unparalleled manufacturer & patient satisfaction across a variety of patietn services models. RareMed’s undivided complex disease focus, high caliber associates, fully dedicated teams, and sophisticated proprietary technology enable it to address the unique needs of complex disease patients. RareMed has been recognized as a top workplace in the nation by USA Today and Newsweek, and consistently sets the benchmark for patient experience according to MMIT patient satisfaction surveys. Visit our website at www.RareMed.com.
About MMIT
For nearly two decades MMIT has been solely focused on solving the “what and why” of drug coverage and has been a trusted, go-to-market partner to pharma companies, payers and providers. We believe that patients who need lifesaving treatments shouldn’t face delays because accessing drugs can be confusing. As the leading provider of market access data, analytics and insights, our expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions.
Divisions of MMIT include AIS Health, creator of the Directory of Health Plans and leading healthcare publications; Zitter Health Insights, a preeminent provider of market access insights and solutions for specialty drugs; RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit; and The Dedham Group, a U.S. market access oncology and specialty therapeutics consultancy offering research, data analytics and strategy formulation services to the life sciences industry.
About Net Promoter Score
The primary component of the MMIT Patient Satisfaction Survey is the Net Promoter Score (NPS). NPS is calculated by first asking patients how likely they would be to recommend a pharmacy to a friend or family member on a scale of 0-10. The percentage of patients that rate the pharmacy a 0-6, known as detractors, is subtracted from the percentage of patients that rate the pharmacy a 9 or 10, known as promoters, to create a score that ranges from –100 to 100. NPS is used by consumer facing companies to gauge consumer and brand loyalty.